Head to head

Envision vs M22 (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: No new-price range is on file for either Envision or M22. Request current quotes to compare purchase costs.
Practice fit: Both are listed under IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL multi-app platform

View full device profile →

Device B

IPL multi-app platform

View full device profile →

Price comparison

Price comparison: InMode Envision vs Lumenis M22
Attribute	InMode Envision	Lumenis M22
New price range	Not published	Not published
Used asking range	Not published	$25k–$50kSource not documented
Payback calculator	View cost details	View ROI calculator
Next step		Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

InMode Envision: Not published
Lumenis M22: Not published

Used asking range

InMode Envision: Not published
Lumenis M22: $25k–$50kSource not documented

Payback calculator

InMode Envision: View cost details
Lumenis M22: View ROI calculator

Next step

InMode Envision

Lumenis M22

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Consumable economics

Consumable economics: InMode Envision vs Lumenis M22
Attribute	InMode Envision	Lumenis M22
Consumable cost / lock-in	—	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Service cost	Not published	Not published

Consumable cost / lock-in

InMode Envision: —
Lumenis M22: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Service cost

InMode Envision: Not published
Lumenis M22: Not published

FDA clearance

FDA clearance: InMode Envision vs Lumenis M22
Attribute	InMode Envision	Lumenis M22
FDA status & indication	FDA ClearedK221571, K210492, K200293 Read FDA indication wording “The InMode Multi System with the Diode laser Applicators is indicated for: • Diolaze XL 810nm Applicator is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. • Diolaze XL 755/810nm & 810/1064nm Applicators are intended for hair removal. • VLaze Applicator is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The InMode Multi System with the IPL Applicator is indicated for: • IPL Applicator with wavelengths (515-1200nm) is indicated for use for the following treatments: The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations. The InMode Multi System with the non-invasive RF Applicators is indicated for: • BodyFX (WMBody) and MiniFX Applicators are intended for the treatment of the following medical conditions: Relief of minor muscle aches and pains, relief of muscle spasm, temporary improvement of local blood circulation; and temporary reduction in the appearance of cellulite. • PLUS/ PLUS90/PLUS-PLUS (FORMA) and i-Forma Applicators are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation. • FaceFX (WMFace) Applicator is intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and rhytids. The InMode Multi System with the Fractional RF Applicators is indicated for: • FRACTORA 60 pin Applicator is intended for use in dermatological procedures requiring ablation and resurfacing of the skin. • FRF 24 pin Applicator is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. • Fractora3D and Morpheus8 Applicators are intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use is limited to Skin Types I-IV.”	FDA ClearedK142860 Read FDA indication wording “The subject Lumenis M22 System has connection capability with the following available treatment handpieces, for multiapplication treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows: 1. The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with 8 different filters) is indicated for: • Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles) and tattoos • Cutaneous lesions, including warts, scars and striae • Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations • Removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • Mild to moderate inflammatory Acne (Acne vulgaris) 2. The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: • The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm. diameter) of the leg • The removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • The non-ablative treatment of facial wrinkles 3. ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: • Use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue 4. The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064nm is indicated for: • Removal of dark tattoos • Treatment of pigmented lesions *Note Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.”

FDA status & indication

InMode Envision: FDA ClearedK221571, K210492, K200293
Read FDA indication wording
“The InMode Multi System with the Diode laser Applicators is indicated for: • Diolaze XL 810nm Applicator is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. • Diolaze XL 755/810nm & 810/1064nm Applicators are intended for hair removal. • VLaze Applicator is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The InMode Multi System with the IPL Applicator is indicated for: • IPL Applicator with wavelengths (515-1200nm) is indicated for use for the following treatments: The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations. The InMode Multi System with the non-invasive RF Applicators is indicated for: • BodyFX (WMBody) and MiniFX Applicators are intended for the treatment of the following medical conditions: Relief of minor muscle aches and pains, relief of muscle spasm, temporary improvement of local blood circulation; and temporary reduction in the appearance of cellulite. • PLUS/ PLUS90/PLUS-PLUS (FORMA) and i-Forma Applicators are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation. • FaceFX (WMFace) Applicator is intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and rhytids. The InMode Multi System with the Fractional RF Applicators is indicated for: • FRACTORA 60 pin Applicator is intended for use in dermatological procedures requiring ablation and resurfacing of the skin. • FRF 24 pin Applicator is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. • Fractora3D and Morpheus8 Applicators are intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use is limited to Skin Types I-IV.”
Lumenis M22: FDA ClearedK142860
Read FDA indication wording
“The subject Lumenis M22 System has connection capability with the following available treatment handpieces, for multiapplication treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows: 1. The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with 8 different filters) is indicated for: • Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles) and tattoos • Cutaneous lesions, including warts, scars and striae • Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations • Removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • Mild to moderate inflammatory Acne (Acne vulgaris) 2. The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: • The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm. diameter) of the leg • The removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • The non-ablative treatment of facial wrinkles 3. ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: • Use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue 4. The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064nm is indicated for: • Removal of dark tattoos • Treatment of pigmented lesions *Note Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.”

Which chains run each

Which chains run each: InMode Envision vs Lumenis M22
Attribute	InMode Envision	Lumenis M22
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

InMode Envision: 0 recorded pairings
Lumenis M22: 0 recorded pairings

Chains using it

InMode Envision: —
Lumenis M22: —

Approved reviews

InMode Envision: 0
Lumenis M22: 0

Specs and platform

Specs and platform: InMode Envision vs Lumenis M22
Attribute	InMode Envision	Lumenis M22
Manufacturer	InMode	Lumenis
Built by (OEM)	—	Lumenis Be Ltd.
Category	IPL multi-app platform	IPL multi-app platform
Technology	—	Universal IPL w/ ExpertFilters + ResurFX + Q-YAG (Nd:YAG)
Launch year	—	2010
Status	Current	Discontinued
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

InMode Envision: InMode
Lumenis M22: Lumenis

Built by (OEM)

InMode Envision: —
Lumenis M22: Lumenis Be Ltd.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Venus Versa Pro

IPL multi-app platform

New: $100k–$130k

Lumenis Stellar M22

IPL multi-app platform

New: $90k–$130k

InMode Optimas

IPL multi-app platform

New: $90k–$130k

SharpLight OmniMax S4

IPL multi-app platform

New: $60k–$90k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.